Efficacy and safety of sucroferric oxyhydroxide in the treatment of hyperphosphataemia in chronic kidney disease in Asturias. FOSFASTUR study

  1. Sanchez-Alvarez, J.E.
  2. Astudillo Cortés, E.
  3. Seras Mozas, M.
  4. García Castro, R.
  5. Hidalgo Ordoñez, C.M.
  6. Andrade López, A.C.
  7. Ulloa Clavijo, C.
  8. Gallardo Pérez, A.
  9. Rodríguez Suarez, C.
Aldizkaria:
Nefrologia

ISSN: 2013-2514

Argitalpen urtea: 2021

Alea: 41

Zenbakia: 1

Orrialdeak: 45-52

Mota: Artikulua

DOI: 10.1016/J.NEFROE.2021.02.005 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus